Greg Chen

I am a physician-scientist developing next-generation cell therapies for cancer, with a focus on understanding and engineering CAR T-cell responses using genomic, single-cell, and computational approaches.

I completed my MD/PhD in Genomics and Computational Biology at the University of Pennsylvania. My PhD involved the use of molecular technologies such as single-cell methods to better understand and improve Chimeric Antigen Receptor (CAR) T-cell therapy for the treatment of cancer. Before joining Penn, I studied at McMaster University, during which I performed computational biology research in the McMaster Department of Chemistry & Chemical Biology as well as at the Ontario Institute for Cancer Research and Princess Margaret Cancer Centre with investigators at the University of Toronto.